中国社区医师Issue(19)：31-32,2.DOI:10.3969/j.issn.1007-614x.2014.19.16
薄芝糖肽、阿米替林联合美托洛尔治疗心血管神经症疗效观察
Observation of Bo Zhi glycopeptide,amitriptyline combined with metoprolol in the treatment of cardiovascular neurosis
杨重明 1胡蓉芳2
作者信息
- 1. 677000云南临沧市人民医院心血管内科
- 2. 677000云南临沧市第二人民医院2
- 折叠
摘要
Abstract
Objective:To investigate the efficacy of Bo Zhi glycopeptide,amitriptyline combined with metoprolol in the treatment of cardiovascular neurosis.Methods:120 cases with cardiovascular neurosis were selected from January 2011 to January 2012. They were randomly divided into two groups.All of them were routine monitored by 24 hour dynamic mentality electrocardiogram(Holter).The control group were given conventional treatment.The observation group were given the Bozhi glycopeptide,amitriptyline combined with metoprolol treatment based on the control group treatment.We observed the changes of dynamic electrocardiogram attitude of the two groups after 2 weeks treatment.Results:The treatment efficiency of the observation group was significantly higher than that of the control group,and the Holter improved of the observation group were significantly better than that of the control group.The incidence of adverse reaction of the observation group was lower than that of the control group.The differences of the two groups between the index contrast were all statistically significant(P<0.05).Conclusion:The clinical effect of Bo Zhi glycopeptide+amitriptyline+metoprolol in the treatment of cardiovascular neurosis is significant.It is beneficial to the patient's clinical symptoms improved,which will contribute to improve the prognosis and quality of life improvement.It has clinical value.关键词
薄芝糖肽/阿米替林/美托洛尔/心血管神经症/疗效观察Key words
Bozhi glycopeptide/Amitriptyline/Metoprolol/Cardiovascular neurosis/Curative effect observation引用本文复制引用
杨重明,胡蓉芳..薄芝糖肽、阿米替林联合美托洛尔治疗心血管神经症疗效观察[J].中国社区医师,2014,(19):31-32,2.
